The Impact of Highly Effective Treatment in Pediatric-Onset Multiple Sclerosis: A Case Series

The Impact of Highly Effective Treatment in Pediatric-Onset Multiple Sclerosis: A Case Series

Introduction: Pediatric-onset multiple sclerosis (POMS) is characterized by high inflammatory disease activity. Our aim was to describe the treatment sequencing and report the impact highly effective disease-modifying treatment (HET) had on disease activity. Materials and Methods: Five consecutive p...

Full description

Bibliographic Details
Main Authors:	Paolo Immovilli, Paola De Mitri, Veronica Bazzurri, Stefano Vollaro, Nicola Morelli, Giacomo Biasucci, Fabiola Magnifico, Elena Marchesi, Maria Lara Lombardelli, Lorenza Gelati, Donata Guidetti
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Children
Subjects:	pediatric onset multiple sclerosis POMS highly effective treatments disease-modifying drugs DMD
Online Access:	https://www.mdpi.com/2227-9067/9/11/1698

Similar Items

Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach
by: Paolo Immovilli, et al.
Published: (2022-04-01)

Patients Monitoring During Treatment With Injectable DMDs (INF and GA) (ORP-11)
by: Zahra Nikoo
Published: (2023-01-01)

Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis
by: Omid Mirmosayyeb, et al.
Published: (2020-05-01)

The Clinical and Epidemiological Profile of Paediatric-Onset Multiple Sclerosis in Poland
by: Waldemar Brola, et al.
Published: (2022-12-01)

Pediatric Onset Multiple Sclerosis and Obesity: Defining the Silhouette of Disease Features in Overweight Patients
by: Laura Papetti, et al.
Published: (2023-11-01)

Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients
by: Hamdy SM, et al.
Published: (2018-02-01)

‘Possessed’: Acute Confusional Migraine in an Adolescent, Prevented by Topiramate
by: Eugenia Rota, et al.
Published: (2012-12-01)

Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset
by: Kano Osamu, et al.
Published: (2013-02-01)

Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis: Case report and literature review
by: Jovićević Vanja, et al.
Published: (2022-01-01)

Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up Study
by: Laura Rosa, et al.
Published: (2022-09-01)

MRI-based diagnostic biomarkers for early onset pediatric multiple sclerosis
by: Martin Weygandt, et al.
Published: (2015-01-01)

Cognitive impairment in paediatric onset multiple sclerosis and its relation to thalamic volume and cortical thickness of temporal lobe by magnetic resonance imaging
by: Nahed S. Ahmed, et al.
Published: (2022-05-01)

Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection
by: Antonia Pignolo, et al.
Published: (2021-12-01)

Age at onset in multiple sclerosis as a possible predictor for cognitive impairment in children and adolescents
by: M. D. Bogdanova, et al.
Published: (2020-08-01)

Basilar invagination: A mimicker of bulbar-onset amyotrophic lateral sclerosis
by: Jason Seng Hong Tan, et al.
Published: (2021-03-01)

Very Late Onset Multiple Sclerosis associated with Restless Legs Syndrome. A case report
by: Isabella Righini, et al.
Published: (2014-03-01)

Muscle Function Differences between Patients with Bulbar and Spinal Onset Amyotrophic Lateral Sclerosis. Does It Depend on Peripheral Glucose?
by: Jose Enrique de la Rubia Ortí, et al.
Published: (2021-04-01)

Initial Cerebellar Ataxia in Hereditary Adult-Onset Primary Lateral Sclerosis
by: José Gazulla, et al.
Published: (2021-06-01)

Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset
by: Chunrong Tao, et al.
Published: (2018-06-01)

Relação dos estados transitórios de humor com a performance em competiçâo de futebol de campo da cidade de Pouso Alegre / MG
by: Gleivinilson dos Santos
Published: (2008-08-01)

Multiple sclerosis in a 4-year-old boy: a case report and literature review
by: Ula Arkar, et al.
Published: (2024-03-01)

Adverse Childhood Experiences Are Linked to Age of Onset and Reading Recognition in Multiple Sclerosis
by: Michael T. Shaw, et al.
Published: (2017-06-01)

New {Co9} cluster-added banana-shaped polyoxometalate modified by B atom
by: Hai-Lou Li, et al.
Published: (2023-09-01)

Exact Solution for Viscoelastic Flow in Pipe and Experimental Validation
by: Ekaterina Vachagina, et al.
Published: (2022-01-01)

Effect of Elasticity Parameter on Viscoelastic Fluid in Pipe Flow Using Extended Pom-Pom Model
by: Mohammad Reza Khorsand Movagar, et al.
Published: (2010-09-01)

Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
by: Monica Margoni, et al.
Published: (2021-05-01)

Genome-wide analyses identify NEAT1 as genetic modifier of age at onset of amyotrophic lateral sclerosis
by: Chunyu Li, et al.
Published: (2023-10-01)

Potential Protective Role of Pregnancy and Breastfeeding in Delaying Onset Symptoms Related to Multiple Sclerosis
by: Alessandra Logoteta, et al.
Published: (2023-03-01)

<i>HLA-DPB1*03</i> as Risk Allele and <i>HLA-DPB1*04</i> as Protective Allele for Both Early- and Adult-Onset Multiple Sclerosis in a Hellenic Cohort
by: Maria Anagnostouli, et al.
Published: (2020-06-01)

Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis
by: Robert Steinbach, et al.
Published: (2021-01-01)

What Can You Learn about Apparent Surface Free Energy from the Hysteresis Approach?
by: Konrad Terpiłowski, et al.
Published: (2021-01-01)

Characterisation of an Industrial Polymer Melt Through Either Uniaxial Extension or Exponential Shear Data: An Application of the Pom-Pom Model
by: Suneel, et al.
Published: (2003-02-01)

COVID-19 and multiple sclerosis: is there a connection?
by: I. E. Arkhipov, et al.
Published: (2024-03-01)

Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review
by: Nicola Capasso, et al.
Published: (2023-06-01)

Horizontal Gaze Palsy and Ipsilateral Facial Nerve Palsy in Older Patient as Initial Manifestation of Very Late-Onset Multiple Sclerosis Successfully Treated with Oral Corticosteroids: A Case Report
by: Tjoa Debby Angela Tjoanda, et al.
Published: (2024-03-01)

Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the <i>mdx</i> Mouse Model for Duchenne Muscular Dystrophy
by: Jessica R. Terrill, et al.
Published: (2023-02-01)

Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS
by: Zbyšek Pavelek, et al.
Published: (2021-01-01)

Mobile Attention Bias Modification Training Is a Digital Health Solution for Managing Distress in Multiple Sclerosis: A Pilot Study in Pediatric Onset
by: Leigh Charvet, et al.
Published: (2021-07-01)

Editorial: Disease modifying therapies in multiple sclerosis
by: Simona Bonavita, et al.
Published: (2022-08-01)

DMD deletions underlining mild dystrophinopathies: literature review highlights phenotype-related mutation clusters and provides insights about genetic mechanisms and prognosis
by: Fernanda Fortunato, et al.
Published: (2024-01-01)